2nd Cell & Gene Therapy Research & Development Congress Asia

Tikva Allocell presented at the 2nd Cell & Gene Therapy Research & Development Congress Asia.

SINGAPORE – 27 May 2024 – The 2nd Cell & Gene Therapy Research & Development Congress Asia, held in Singapore from April 17th to 18th, 2024, was a remarkable event that brought together leading experts in the field. The congress showcased groundbreaking developments in cell and gene therapy from vibrant epicentres of research such as Singapore, China, South Korea, and Japan. It highlighted significant contributions in the field of cell and gene therapy. To this, Dr. Tong Cheuk Ka, Director for Strategy and External Collaboration at Tikva Allocell provided a survey of the challenges and opportunities of cell therapy in Asia and how Singapore and Tikva Allocell are in a good position to capitalize on them.

The congress also discussed how regulatory frameworks have been adapted to foster a research-friendly environment, encouraging collaboration between academia and industry. With more than 15 talks and panel discussions across two days, the congress provided ample opportunities for attendees to connect and collaborate. In one of the panel discussions, Ms Clare Tan, Director for Clinical Operations and Project Management at Tikva Allocell discussed Asia’s role in shaping the future of cell therapy, diving into innovations, collaborations, and market trends. Clare shared about the importance of early and active engagement with regulatory agencies for filing investigational new drug (IND) application, and taking advantage of the different patient demographics, advance healthcare system, and clinical research ecosystem.

The 2nd Cell & Gene Therapy Research & Development Congress Asia was a great success. The congress not only highlighted the triumphs in the field but also addressed the challenges, paving the way for future advancements in cell and gene therapy.

Jinkai TEO, MSc

Principal Data Scientist

Jinkai brings more than 10 years of experience in the pharmaceutical industry spanning from the bench as a translational scientist to managing CMC activities (analytical and process development). He obtains his MSc in Statistic from NUS (Singapore) and BSc in Chemistry and Biochemistry from NTU (Singapore).

Share the Post:

Related Posts